Figure 4.

Effects of GOS/inulin supplementation during pregnancy on hematopoietic stem and progenitor cell frequency in bone marrow from dams and fetuses. (A) Gating strategy used after immunostaining to evaluate all HSC and progenitor cell subsets. (B) Assessment of common lymphoid progenitor (CLP), common myeloid progenitor (CMP), megakaryocyte-erythrocyte progenitor (MEP), granulocyte-macrophage progenitor (GMP) and common DC precursor (DCP) frequencies in the bone marrow of dams and pups fed a control diet (white) or supplemented with GOS/inulin (gray) (n=12).